The role of arginine in the binding of LTD4 antagonists to cysLT1 receptors of guinea pig lung

Bioorganic and Medicinal Chemistry Letters

Volumn 7, Issue 10, 1997, Pages 1331-1336

  Zhang, Ming Qiang ^a   Zwaagstra, Mariël E ^a   Nederkoorn, Paul H J ^a   Timmerman, Henk ^a  

^a VU UNIVERSITY AMSTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1 [2 METHOXY 4 [(PHENYLSULFONYLAMINO)CARBONYL]BENZYL] 1H INDAZOLE 6 CARBAMIC ACID CYCLOPENTYL ESTER; ANTIASTHMATIC AGENT; LEUKOTRIENE D4; LEUKOTRIENE RECEPTOR; LEUKOTRIENE RECEPTOR BLOCKING AGENT; PEPTIDOLEUKOTRIENE; PHENYLGLYOXAL; PRANLUKAST; RECEPTOR SUBTYPE;

AMINO ACID COMPOSITION; ANIMAL TISSUE; ARTICLE; BINDING SITE; CONTROLLED STUDY; DRUG DESIGN; DRUG RECEPTOR BINDING; GUINEA PIG; IN VITRO STUDY; LUNG; NONHUMAN; PROTEIN STRUCTURE; STRUCTURE ACTIVITY RELATION;

EID: 0031579966     PISSN: 0960894X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-894X(97)00219-9     Document Type: Article

References (27)

1. Dahlén, S.E.; Hedqvist, P.; Samuelsson, B.; Taylor, W.A.; Fritsch, J. eds, Leukotrienes as Mediators of Asthma and Inflammation: Basic and Applied Research, Raven Press, Ltd: New York, 1994.
2. (a) Brooks, C.D.W.; Summers, J.B. J. Med. Chem. 1996, 39, 2629;
3. (b) Harris, R.R.; Carter, G.W.; Bell, R.L.; Moore, J.L.; Brooks, D.W. Int. J. Immunopharmac. 1995, 17, 147;
4. (c) Gorenne, I.; Norel, X.; Brink, C. Trends Pharmacol. Sci. 1996, 17, 342;
5. (d) Holgate, S.T.; Bradding, P.; Sampson, A.P. J. Allergy Clin. Immunol. 1996, 98, 1;
6. (e) Hay, D.W.P.; Torphy, T.J.; Undem, B.J. Trends Pharmacol. Sci. 1995, 16, 304-309;
7. (f) Mayatepek, E.; Hoffmann, G.F. Pediatric Res. 1995, 37, 1;
8. (g) Henderson, W.R. Ann. Intern. Med. 1994, 121, 684;
9. (h) Chanarin, N.; Johnston, S.L. Drugs 1994, 47, 12;
10. (i) Shaw, A.; Krell, R.D. J. Med. Chem. 1991, 34, 1235.
11. Merluzzi, V.J.; Adams, J. eds, The Search for Anti-Inflammatory Drugs, Birkhäuser: Boston, 1995.
12. Gorenne I., Norel X., Brink C. Trends Pharmacol. Sci. 17:1996;342-345.
13. (a) Terada, H.; Goto, S.; Hori, H.; Taira, Z. In QSAR and Drug Design - New Development and Applications; Fujita, T., Ed.; Elsevier Science B.V.: Amsterdam, 1995; pp341-367.
14. (b) Goto, S.; Guo, Z.; Futatsuishi, Y.; Hori, H.; Taira, Z.; Terada, H. J. Med. Chem. 1992, 35, 2440-2445.
15. (c) Harper, R.W.; Herron, D.K.; Bollinger, N.G.; Sawyer, J.S.; Baldwin, R.F.; Roman, C.R.; Rinkema, L.E.; Fleisch, J.H. J. Med. Chem. 1992, 35, 1191-1200.
16. (d) Hermann, R.B.; Herron, D.K. J. Compt.-Aided Mol. Design 1991, 5, 511-524.
17. Weichman B.M., Wasserman M.A., Holden D.A., Osborn R.R., Woodward D.F., Ku T.W., Gleason J.G. J. Pharmacol. Exp. Ther. 227:1983;700-705.
18. Aharony D., Falcone R.C., Yee Y.K., Hesp B., Giles R.E., Krell R.D. Ann. N.Y. Acad. Sci. 524:1988;162-180.
19. Zwaagstra, M.E. PhD Thesis, Vrije Universiteit Amsterdam. 1997.
20. (a) Hariprasad, V.; Kulkarni, V.M. J. Compt.-Aided Mol. Design 1996, 10, 284-292.
21. (b) Palomer, A.; Giolitti, A.; Garcia, M.L.; Cabré, F.; Mauleón, D.; Carganico, G. In QSAR and Molecular Modelling: Concepts, Computational Tools and Biological Applications. Sanz, F.; Giraldo, J., Ed.; Prous Science Publishers: Barcelona, 1995; pp444-450.
22. (a) Galemmo, R.A. Jr; Johnson, W.H. Jr; Learn, K.S.; Lee, T.D.Y.; Huang, F.C.; Campbell, H.F.; Youssefyeh, R.; O'Rourke, S.V.; Schuessler, G.; Sweeney, D.M.; Travis, J.J.; Sutherland, C.A.; Nuss, G.W.; Carnathan, G.W.; Van Inwegen, R.G. J. Med. Chem. 1990, 33, 2828-2841.
23. (b) Yee, Y.K.; Bernstein, P.R.; Adams, E.J.; Brown, F.J.; Cronk, L.A.; Hebbel, K.C.; Vacek, E.P.; Krell, R.D.; Snyder, D.W. J. Med. Chem. 1990, 33, 2437-2451.
24. Masamune H., Eggler J.F., Marfat A., Melvin L.S. Jr., Rusek F.W., Tickner J.E., Cheng J.B., Shirley J.T. Bioorg. Med. Chem. Lett. 5:1995;1371-1376.
25. (a) Communi, D.; Lecocq, R.; Van Weyenberg, V.; Erneux, C. Biochem. J. 1995, 310, 109-115.
26. (b) Ghosh, M.; Datta, A.K. Biochem. J. 1994, 298, 295-301.
27. Zhang M.Q., Wada Y., Sato F., Timmerman H. J. Med. Chem. 38:1995;2472-2477.